Name | Entity | Relationship | Benefit to Individual | Benefit to Institution |
Rick Varma (chair) | None | N/A | ||
Andrew Grulich | Seqirus | Grant/grants pending | X | |
Cancer Council NSW | Grant/grants pending | X | ||
American Foundation for AIDS Research | Grant/grants pending | X | ||
Gilead | Educational presentations | X | ||
Merck | Educational presentations | X | ||
NHMRC | Travel expenses | X | ||
Cure Cancer Australia | Advisory Board Member | X | ||
NSW Ministry of Health | Grants pending | X | ||
ViiV Healthcare | Educational presentations | X | ||
Advisory Board Member | X | |||
Arron Sparkes | ViiV Healthcare | Advisory board meetings, honoraria | X | |
Gilead Sciences | Honoraria, Grant/grants pending, Travel/accommodation expenses | X | ||
Brent Clifton | None | N/A | ||
Craig Burnett | None | N/A | ||
Danielle Collins | None | N/A | ||
David Nolan | None | N/A | ||
Lewis MacKinnon | ViiV Healthcare | Travel expenses | X | |
Advisory board membership | X | |||
Educational activities | X | |||
WA Department of Health | Educational activities | X | ||
Novartis | Educational activities | X | ||
Travel expenses | X | |||
Astra Zeneca | Educational activities | X | ||
Advisory board consulting | X | |||
Mark O’Reilly | ViiV Healthcare | Advisory board meetings | X | |
Grant/grants pending | X | |||
Honoraria | X | |||
Gilead Sciences | Advisory board meetings | X | ||
Honoraria | X | |||
Travel/accommodation expenses | X | |||
Rupert Handy | None | N/A |
Menu
Financial Disclosure
Guidelines > Financial Disclosure
Table of Contents
Adult Guidelines > Financial Disclosure
Sections
Menu
Table of Contents
Menu
Menu
The ARV Guidelines with Australian commentary is administered by ASHM
The Australian Government Department of Health
While the Australian Department of Health provides financial support for the ARV Guidelines, the material contained in this resource should not be taken to represent the views of the Australian Department of Health.